{"id":12476,"date":"2022-05-04T13:04:53","date_gmt":"2022-05-04T13:04:53","guid":{"rendered":"https:\/\/financialtelegraph.in\/index.php\/2022\/05\/04\/dr-ashleys-limited-infuses-academic-researchers-on-board-inducts-top-strategists-in-advisory-board\/"},"modified":"2022-05-04T13:04:53","modified_gmt":"2022-05-04T13:04:53","slug":"dr-ashleys-limited-infuses-academic-researchers-on-board-inducts-top-strategists-in-advisory-board","status":"publish","type":"post","link":"https:\/\/financialtelegraph.in\/index.php\/2022\/05\/04\/dr-ashleys-limited-infuses-academic-researchers-on-board-inducts-top-strategists-in-advisory-board\/","title":{"rendered":"Dr Ashleys Limited infuses academic researchers on Board, inducts top strategists in Advisory Board"},"content":{"rendered":"
\"\"<\/div>\n

One of Europes\u2019s Most renowned Economist Prof Dr Nina, Director, Director of Department of Economics at The Latvian Acadamy of Sciences and AS Lights Director Mr Gerhald to guide HOPSTEDTER<\/em><\/strong>\u00a0<\/strong><\/p>\n

Hong Kong, May 4<\/strong>:\u00a0\u00a0Dr Ashleys Limited<\/a>\u00a0, the Hong Kong based pharmaceutical Company today announced the induction of noted & eminent global researchers as advisors to the board of directors. Europes\u2019s most renowned Economist Prof Dr Nina Linde, ,\u00a0 Director of Department of Economics at The Latvian Acadamy of Sciences\u00a0 and\u00a0 AS Lights Director Mr Gerhald\u00a0 Hopstedter will be guiding & advising the\u00a0 Dr Ashleys Limited\u2019s Board of Directors in building\u00a0 the company as a strong international pharmaceutical company in its pursuit to its mission to widen its academic excellence.<\/p>\n

Announcing the appointment of two seasoned academic researchers as Advisors, {Prof} Dr. Kannan Vishwanatth, Managing Director of\u00a0Dr Ashleys Limited said \u201cWe are pleased to announce\u00a0Dr Nina Linde and Mr Mr Gerhald\u00a0Hopstedter on our Board. We can\u2019t wait to see how our highly experienced board members will enlighten us to develop the vision and purpose of building\u00a0Dr Ashleys in the market by advising on matters of strategic importance, leverage decades of top-tier industry experience, broaden and deepen our relationships, and ensure continued growth and success.<\/p>\n

Dr Nina Linde has broad leadership experience in corporate management and academia. She is an international speaker recognized by peers, executives, and students with numerous awards for her innovative leadership and passion for teaching. She inspires students from both business and engineering disciplines in his courses for open innovation, business models, smart cities, scalable smart villages, and business models for emerging economies…<\/p>\n

Before joining the academy of Sciences Latvia Dr Linde has been the Advisor to Ministry of education in Latvia, Mr Gerhald\u00a0Hopstedter is a noted author & research analyst. Dr Satya is the founder chairman of AS Lights and Balticsmagazine,\u00a0Baltics states\u00a0 most acclaimed research firm engaged in timely, in-depth analysis of companies, industries, markets, and world economies. Mr Gerhald\u00a0Hopstedter is also the author of many top books Mr Gerhald is most respected & distinguished entrepreneur\u00a0& known for championing the cause of Citizen\u2019s rights & free speech.<\/p>\n

Dr Ashleys Limited is a research-focused vertically integrated pharmaceutical Company, which Contract manufactures active pharmaceutical ingredients and is in contract research and manufacturing services (CRAMS). The Company is a market leader in the Antimalarial API segment and is the world\u2019s third-largest contract manufacturer of Quinine salts. It also exports its products to more than 60 emerging countries in Africa, Central and South America, and Asia.<\/p>\n","protected":false},"excerpt":{"rendered":"

One of Europes\u2019s Most renowned Economist Prof Dr Nina, Director, Director of Department of Economics at The Latvian Acadamy of Sciences and AS Lights Director Mr Gerhald to guide HOPSTEDTER\u00a0 … Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":12477,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[448],"class_list":["post-12476","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-business","entry"],"_links":{"self":[{"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/posts\/12476","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/comments?post=12476"}],"version-history":[{"count":0,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/posts\/12476\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/media\/12477"}],"wp:attachment":[{"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/media?parent=12476"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/categories?post=12476"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/tags?post=12476"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}